Posts Tagged ‘Pfizer’

  A couple of weeks ago, I shared some statistics that I learned from an FDA blog post about rare diseases. While those numbers will make you cringe, Pfizer will give you hope. They, along with Spark Therapeutics, are teaming up to develop treatments for rare diseases, like hemophilia, through gene therapy. Gene therapy is […]

  If you visit the Gloucester Police Department’s Facebook page, you’ll notice their posts from September 16th and 18th received thousands of likes, shares, and comments. That’s for good reason. On September 16th, the department called out five pharma CEOs with the highest salaries and urged readers to contact them and ask what they’re doing […]

  Life sciences organizations are in the business of developing drugs and medical devices. Hitting key milestones and moving trials to the next phase has always been a priority. Throughout this entire process, the collection and analysis of clinical and safety data is essential in taking products to subsequent stages, and ultimately getting them approved […]

  There’s a lot of talk these days about digital transformation: changing the way companies interact with their constituents. In general, the movement has not focused on specific groups of people…until now. 

  According to a recent letter written in the South China Morning Post by Chien Wai-tong, a professor and the associate head (of research) in the school of nursing at Hong Kong Polytechnic University, one in about every four people in Hong Kong has been affected by a mental health issue at some point in […]

  When you think of a pharmaceutical companies, you think drugs. You think of them as a business – drugs being developed, sold, and consumed. Not often do you think of them as do-gooders. 

  If you really think about it, it’s quite astonishing that Viagra sales in 2014 grew 47% in China, a country in which discussing sexual health-related topics has long been considered taboo. So, what caused this surge in sales?